The proposed study is a multicenter, prospective, randomized controlled trial that will compare the three currently available treatment options for patients with frozen shoulder. Study will include a 3-week treatment phase followed by a 12-week follow-up phase. Figure 1shows the trial procedure and Table 1 illustrates the trial schedule. 108 FS patient will be recruited and randomized into one of three groups in a 1:1:1 ratio of the Stuck-moving Needle acupuncture, common acupuncture control group and physical exercise control group. Patients as a subject will be recruited from 3 clinical centers of Qingyang Traditional Chinese Medicine Hospital, Qingyang Xifeng district People's Hospital and Qingyang Second People's Hospital from February 2020 to January 2021. All patients will be required to provide written consent to participate in the study. The study has been approved by the Ethics Committee of the Qinyang hospital of Chinese Medicine (No.2019-12-001). Further, we have registered in the Acupuncture-Moxibustion Clinical Trial Registry (ChiMCTR1900002862) and Chinese Clinical Trial Registry (ChiCTR1900028452).
The inclusion criteria for patient selection is as follows:
(1) The age shoulder between 40 to 70 years old.
(2) Shoulder pain is self-reported. Whereas the pain range extends from the medial side of the shoulder to the biceps area or the outside of the deltoid muscle. The VAS score is between 7-8 points.
(3) The onset of pain lasts for at least three months.
(4) The stiff shoulder pain is a spontaneous attack, and the shoulder lifting or external rotation function is lost by 50%, and the OSS score is between 50-60 points.
(5) Being able to actively cooperate with the doctor and sign the consent form to voluntarily receive acupuncture treatment.
The exclusion criteria for patient selection is as follows:
(1) The patient has received other treatments that may affect the effect indicators of this study, including oral painkillers for nearly three months and physical therapies such as acupuncture and massage.
(2) The patient has severe life-threatening primary diseases related to liver and kidney, cardiovascular and cerebrovascular diseases, and mental illness.
(3) Patients who are pregnant or breast-feeding which do not meet the inclusion criteria.
(4) Exclude other factors related to the diseases such as the history of shoulder trauma within one month, shoulder tuberculosis and tumor, rheumatoid arthritis, rheumatic arthritis, gouty arthritis, shoulder subluxation of stroke sequelae, shoulder pain caused by cervical spondylosis, reflex shoulder pain caused by heart or biliary tract disease.
Note: Patients who meet any of the above criteria will be excluded immediately.
Recruitment, randomization, allocation concealment, and blinding
Patients will be recruited via advertisements on hospital website and notice board of clinics.
Random and Allocation of Hidden Methods
The number of observed subjects will be allocated based on the actual situation of each center. The subjects in each center will be divided into three groups by random number table method and serial numbers will be allocated ( such as 1, 2, 3, ..., N, this serial number is the ID of the subjects who will participate in the study). Then starting from any number on the random number table, the number of subjects will be selected in the sub-center. SAS (v9.4) software will be used to generate the random numbers corresponding to the above serial number. The number will be divided by 3, if the remainder is 0, then the subject will be included in the acupuncture myofascial triggers points group. If the remainder is 1, subject will be included in the common acupuncture group, and if the remainder is 2, then the subject will be included in the functional exercise group. According to the result of the grouping, the random card will be made, sealed in an opaque envelope, and will be kept by a responsible person. In the clinical implementation, the order in which the qualified subjects will be included in the test is in one-to-one correspondence with the sequence number on the envelope, and the envelopes will be opened and grouped according to the prompts on the random card.
This study will use the blind method for evaluation. Efficacy assessments will be performed by third parties who do not know the grouping situation. Further, all participants in the assessment will receive uniform training. Blind statistical analysis will be used in the data summary stage, that is, statistical analysts will be unaware of the grouping situation and content. Randomized staff, study researchers, operators, and statisticians will be kept unaware of the experiment blinded to ensure that subjects, evaluators, and statisticians do not understand the grouping situation.
Participants will be randomly allocated into one of three groups: A- the stuck-moving needling acupuncture MTrp group, B- the common acupuncture group, and C- the Physical exercise group as the control group and the basic therapy for group A and B. Three acupuncturists with at least five years of clinical experience in acupuncture practice will be recruited from Chinese Medicine Practitioners, and only these acupuncturists will be allowed to perform all acupuncture sessions. Several training sessions will be carried out prior to the commencement of the study which will ensure consistency in the skills of the acupuncturist. During the 3-week treatment period, patients will receive nine sessions of acupuncture (3 weekly cycles of one treatment every other day, followed by a 1-day break). One-time stuck-moving needles (0.40mm×40mm/ 0.40×25 mm, the patent of li zhenquan produced, Beijing, China), One-time acupuncture sterile needles (0.25 mm×40 mm/ 0.25×25 mm, Hwato, Suzhou, China) will be used in the trial. All acupuncture treatments will be provided for free to improve adherence to the intervention protocol. Patient and acupuncturist signatures will be required after each acupuncture session to monitor adherence. Other treatments that may affect the effect indicators of this study will be prohibited, including oral painkillers for nearly three months and physical therapy such as acupuncture and massage.
Group A: Stuck-moving Needle Acupuncture MTrp Treatment Group
Selection and positioning method of shoulder joint myofascial trigger pain points
The selection of shoulder joint myofascial trigger pain points will be achieved by a dynamic search. Further, patients will be subjected to do three actions including the first one as abduction, lifting, and touching the head. The second one is forward flexion and internal rotation by touching the opposite shoulder. The third one is a posterior extension and patient’s back. These three actions can indicate the patient’s pain area. At the same time, the doctor will use his or her thumb to press these areas and confirms the muscle tension band. The compression can lead to localized pain and muscle spasm and strengthen the stimulation to induce the mentioned pain. Once the pain is induced, the doctor will ask the patient if the pain is similar to what he or she usually feels. If the pain is similar to the pain patient usually feels, then the doctor will place a pressure manometer on the main tenderness point to evaluate the pain point. Further, by placing the pressure manometer (Wagner Instruments, USA, specification model: FDK20) at the pain area, slowly pressure will be applied. Using this equipment, doctor can measure the tenderness threshold, and can remove the pain points below the tenderness threshold of 2kg/cm2. After locating the pain points, the doctor will use a black pen to draw “×” on it.
The stuck-moving needle acupuncture method
The patient will take a seated position during acupuncture. After routine disinfection on the selected myofascial trigger points (MTrp), the skin will be cleaned with alcohol (75%). The applicator will tighten the patient’s skin with his or her left hand, and will hold the stuck-moving needle (specification: 0.40 × 40mm ) in his or her right hand (the position of the needle is approximately 1cm from the needle tip), and the stuck-moving needle will be inserted perpendicularly into the Trp (the degree of convulsions after the patient’s pain is triggered). Further, a needle will be twisted clockwise slowly (90-180 degrees) until the muscle fibers are wounded and until the needle becomes tight and twisted At this point, patient may describes pain and astringency. Then the needle will be lifted again with 3 to 5 times shaking The strength of lifting the needle will depends on the patient’s condition and acupuncture position. Further, a needle should be ejected quickly. While lifting the needle, the doctor will twist needle counter clockwise until the muscle fibers are relaxed. After the treatment, the patient will be supplemented with physical exercises. The exercise method is same as provided to Group C.
Treatment course:1 treatment every other day, three treatments per week, total of 9 treatments for 3 weeks.
Group B: Common Acupuncture Control Group
Acupoints: Jianyu (LI15), Jianliao (TE 14), Jianzhen (SI 9), Biru (LI14), Ashi points.
Method of operation: The patient will be taken the lateral position and exposes the affected side of the shoulder. After routine sterilization of the acupuncture site, a milli needle with a diameter of 0.25 mm and a length of 40-50 mm will be used. The acupoint locations are based on the “2006 People’s Republic of China National Standard” (GB/T1234–2006), and the acupuncture operation is based on the textbook of the 12th Five-Year Plan of the Ministry of Health. The skin will be cleaned with alcohol (75%). Then needle will be quickly pierced into acupoints with the depth of 1.9-2.6 inches, and twirling the needle until “De qi”. After using the mild reinforcing-attenuating method, the needle is retained for 30 minutes. After daily acupuncture, exercise will be provided which is as same as Group C
Treatment: 1 treatment every other day, 3 times a week, 9 times for 3 weeks.
Group C: Physical Exercise Control Group
The physical exercise method of the shoulder joint is carried out according to the physical exercise program recommended in the Evidence-based clinical guidelines for the diagnosis, “The Assessment and Physiotherapy Management of Contracted (frozen) Shoulder” prepared by Hanchard N et al  in 2012. The patient's training will be consisted of 12 sports units, including active and passive training, for a total of 50 minutes. Each workout will have a professional physiotherapist (Cheng Maomao physical therapist) to guide the treatment and provide a practical exercise program for the patient. Three times a week, treatment will be lasted for nine weeks for a total of 9 treatments. Basic action will be involved in active exercise without an instrument on the shoulder joint. The pained shoulder joint will be considered as the center and small rotation will be made, first clockwise for 4 minutes, then counterclockwise for 4 minutes and alternatively for 20 minutes. In the later stage, strength of exercise will be increased with the help of the physiotherapist, and the passive movement will be carried out for 10 minutes. Then, it will be used for shoulder flexion, abduction, extension and internal rotation, external rotation and other actions by means of assistive devices such as shoulder rotation training device and fitness ball technique. Finally, the standing training exercises will be carried out for the spine and side bends of the spine.
Measures to improve patient adherence
On a voluntary basis with the signed informed consent, patient’s adherence will be improved using the subject manual and Short Messaging Service (SMSThe acupuncturists will possess at least five years of clinical experience in acupuncture practice. This is to ensure that the treatments will be administered consistently.
The following outcomes will be assessed by independent outcome assessors. These assessors will be trained before participating in this trial and unaware of the group assignments. The outcome assessments will be performed at four-time points including at the baseline, at the end of the stuck-moving needle acupuncture treatments, in the 4 weeks follow-up period and at the end of the follow-up period.
Main Outcome Indicators
The primary evaluation index in the trial will be the change involved in the scores on the Visual Analogue Scale (VAS) and measurement of range of joint motion (ROM) from the baseline period through the 12-weeks of the follow-up period.
Visual Analogue Scale (VAS): The VAS for pain assessment is widely used in China. The basic method is to use a 10cm long swimming ruler which have ten scale on one side and the two ends of the ruler are with the digits 0 and 10. '0 point' indicates no pain, and '10 point' represent the most severe pain which is unbearable. During the assessment, the scaled side is faced back to the patient, and the patient marks on the ruler with the scale points that represents his or her pain level, and the physician records the score based on the position marked by the patient.
Measurement of Range of Joint Motion (ROM): The degree of mobility of the shoulder joint was measured using the American muscle strength test and the joint mobility meter (portable) (Hoggan MicroFET3). This study will measure the angle of the shoulder flexion, extension, abduction, internal rotation, and external rotation.
Measurement of pressure pain threshold (PPT) and Pressure pain tolerance (PTT): This study will be performed using the FDK20 handheld pressure an algeometer manufactured by Wagner Instruments, USA. The device measures the individual's pain sensitivity by applying pressure which includes measuring the pressure pain threshold (PPT) and the pressure pain tolerance (PTT). Initially, the data that will be transferred to the tester when the subject just felt pain, which will be recorded as PPT. Further, after a short pause, the pressure will be increased until the pain becomes intolerable to the subject. Then the tester will be informed the second time to recorded PTT. The test value is visible only to the tester during the whole process. The order of the test points is 1>2, and the test interval of different test points is 5 min. The data will be analyzed in units of kg/cm2.
Oxford Shoulder Score (OSS): The OSS consisted of 12 questions. These questions were related to the pain (1~4 questions) and functional activities (5~12 questions). There are five alternative answers for each question. The best case is 1 point, the worst is 5 points, and the total score will be between 12 to 60 points. The higher the score, the worse the shoulder function will be.
Short Form-36 Questionnaire (SF-36): The quality of life assessment scale includes 36 questions, which are related to the general health problems, physical function problems, limitations of daily life due to physical strength and physical pain, social skills, psychological repression and well-being, as well as functional limitations caused by emotional problems.
Patient Satisfaction Evaluation: This scale will allow patients to provide medical services according to this study, and to evaluate this treatment in a true and objective manner.
Sample Size Estimation
According to the previous researches, the difference between the VAS score before and after treatment in the general acupuncture group was 4.7, with a standard deviation of 1. Whereas, the difference in VAS score before and after treatment in the functional exercise group was 3.5, with a standard deviation of 1 (Mahsa Asheghan et al.,2016). In combination with the pilot experimental results from this study, the VAS score before and after treatment of frozen shoulder patients with Stuck-moving needle acupuncture dropped by 5.2 and the standard deviation was 1.06. This study was a prospective study with three groups and the sample size as 1:1:1. The sample size was calculated using F-test in software SAS 9.4, and we used single factor analysis of variance to calculate the sample size. The test level was set at α = 0.05, β = 0.1, and the test efficiency was set at 1-β = 0.9. The results showed that the test power was 0.931, and the number of samples in each group was not less than 30. By considering the problem of missing samples or losing to follow-up, the sample size will be increased by 20. This means that the minimum sample size of each group will be 36 patients, and finally the total sample of the three groups will include cases not less than 108.
All adverse events that will occur during the study will be recorded. The records will include the description of these events, start time, severity and frequency of occurrence, end time, ongoing treatment, results, and the track and analysis.
(1) A serious adverse event (SAE) is an adverse event in which any of the following circumstances can occur.
- An event that causes the patient to die or endanger the patient's life.
- The events that result in permanent or significant disability or loss of function in the patient.
- The events that lead to hospitalization.
- The important medical events need to use drugs or surgery to prevent serious consequences.
(2) Treatment of serious adverse events
Once a serious adverse event is found, the study physician must report to the study leader and the study team. The study team should report to the Ethics Committee and the responsible units within 24 hours, and record the serious adverse events in the original data. Original data may include carefully filling out the adverse event report form, recording the start time, the severity, the final outcome, the relationship with acupuncture treatment, the details of the treatment, and should immediately consult the relevant departments to take the necessary treatment.
The trial of a SAE patient will be discontinued and become a withdraw subject, while all costs for handling adverse events will be covered by this study.
The project will evaluate the safety of vital signs and the incidence of adverse acupuncture reactions.
(1) Vital signs will include: Post-treatment respiration, heart rate, blood pressure, and body temperature.
(2) Incidence of adverse events: Adverse events will be referred as any unintended symptoms, signs or health conditions that occurred after the start of the study. However, adverse events will not have a relationship with the treatment of this study. Adverse events include dizziness, hematoma, bleeding, infection, and abnormal pain at the treatment site. The number of adverse reactions will be counted at the end of the study, divided by the total number of each group, and the analysis will be carried out for the adverse events.
(3) Compliance analysis：The patient's compliance with the treatment will be counted by the number of treatments. The formula is as follows: treatment compliance = the number of treatments the patient has received / the number of treatments the patient should receive × 100%.
All statistical analysis will be carried out by the professionals using SPSS (v21.0) software. As well as the participants in the statistical analysis will be unaware for the specific grouping content of the trial. This study will use a Full Analysis Set (FAS) and Per Protocol Set (PPS), and the final conclusion will be based on FAS. The Full Analysis Set (FAS) is based on the Intent to Treatment (ITT). Patients who participate in randomization and receive at least one treatment will be included in the analysis. In the FAS analysis, patients who do not complete the trial, the main indicators of the missing will be derived from the Last Observation Carried Forward (LOCF). Continuous variables will be presented as mean ± standard deviation (normally distributed data) or medians and ranges (non-normally distributed data). Frequencies and percentages will be used to count the data. All statistics will be performed by bilateral differential test, with P value< 0.05 will be considered statistically significant.
For the balance of basic values, analysis of variance or chi-square test or rank sum test will be used. For the primary and secondary outcome, the analysis of variance will be used. If confounding factors have an impact on the results, then the co-variance analysis will be used. For the safety analysis, the incidence of three groups of adverse events will be compared using a chi-square test, and the adverse events that will occur in this trial listed. At the same time, the paired t-test will be used to compare the differences between the groups before and after treatment. The comparison among the three groups before and after treatment will be analyzed by variance. The rate changes before and after treatment in the three groups will be measured by chi-square test or non-parametric test.
(1) This study will use a randomized control design, and the randomization protocol will be held by the management team of the study team who do not participate in the project to ensure random allocation and control biases.
(2) This study is limited to the inclusion criteria, and will establish a clear inclusion and exclusion criteria to control biases.
(3) This study will use blind method evaluation, and will evaluate the efficacy and safety by evaluators who do not know the grouping situation to ensure the reliability of the research results.
(4) During the study, the pain tester, muscle strength and joint mobility test will be carried out according to various standard operating procedures to control biases.
(5) The quality control inspection of this study will be conducted by the researcher to designate at least one non-quality implementer to conduct a quality check on the research of each center of the subject to control the bias.
Initial meeting of the project will be held to conduct unified training. Key training will be carried out on the project implementation plan and SOP, so that each participant will master the research process and specific implementation rules to ensure the reliability of the conclusion. During the study, each center will be supervised regularly to control biases.
Data Collection and Management
Paper CRFs will be used to record all the information required from the protocol which will be collected from the hospital. There will be an instructions page at the start of each postal questionnaire and for the more complex hospital CRFs. Each trial participant will have a unique identification number that will be pre-recorded on all CRFs. Initially, the data will be listed on the CRF form, and after interviewing 20 participants, the data of clinical research will be input in a group of 20 cases. Besides, the input approach will be double-input, which will be in-put by two data input personnel without contact. Meanwhile, the data manager will compare the differences with the initial data and fill in the reasons for it. During the trial, a monthly data inspection will be needed, and the content involves data assembled by every center abnormal data, and delayed data in progress tracking. The data input in the paper type of CRF form will be received from the primary data. Furthermore, the researcher will preserve the copies of the test-related data, the data of the subject, and all other initial data until the announcement from the team leader to discard them. Moreover, researchers at the center should obey the rule of confidentiality of the trial. After the primary data which will be held for three years, non-research team members cannot browse and borrow it.
Data Monitoring and Auditing
As this test is a multi-center study, therefore, before the start of each research center, the team leader from every unit will monitor the research center. They will check whether the research-related facilities and equipment are complete and well prepared, and whether or not the researchers are proficient in the test operation process and equipment use. The chief investigator of the team leader unit will inform each clinical center investigator of their responsibilities, and how to correctly and completely fill in the relevant documents for the trial. Through the investigator training session, the investigator and his team will understand the trial plan, completing the CRF form, use of the evaluation tools, as well as the test procedures. Then the chief investigator of the team leader unit will visit the start-up status of each center. During the test, the third-party data management staff will regularly and strictly monitor the filling of the CRF form. The third-party data management staff will mainly monitor whether the researcher screens the subjects in accordance with the admission criteria. During the inspection, the CRF form will be checked if it is accurate, directly with reference to the original data.
(1) Before conducting a conversation with the subject, the researcher should understand and check whether the informed consent is comprehensive, whether it meets the ethical requirements, and whether it meets the rights and obligations of the subjects as specified in the “Helsinki Declaration”.
(2) Explain the entire contents of the informed consent form to the subject in a simple and understandable language. The subject will voluntarily participate in the clinical trial and has the right to withdraw at any stage of the trial without discrimination and retaliation. The personal data and information of the participants participating in the trial will be kept confidential, and subjects may be assigned to different trial groups to take different treatments. Informed consent should be signed by the subject or other legal representative.
Investigators will have the authority to terminate patient participation at any time if the investigator deems it is in the best interests of the patient. Termination criteria are as follows: (1) Patients with serious adverse reactions or combined with other critical illnesses in the study. (2) The subject asks to withdraw from the trial during the course of treatment and persuasion is ineffective. (3) Subjects who are not cooperating to the treatment and persuasion is ineffective by the doctor. (4) If the subject receives half of the treatment, then he or she should be included in the statistical analysis of efficacy.
This study will not provide any post-trial care.
If the protocol changes during the implementation of the study, researchers will communicate the important protocol modifications (e.g., changes to eligibility criteria, outcomes, analyses) to the relevant parties, including the fund regulator, trial participants, trial registries and journals.
This study follows the ethical principles set out in the “Helsinki Declaration” and the various laws and regulations related to clinical research in China. Patients may receive acupuncture treatments such as trigger points during the study. Moreover, patients will receive free color Doppler ultrasound, muscle strength measurement, pain threshold measurement, Infrared thermography and various evaluation tests. Some patients may experience fainting, pain, bleeding, hematoma or infection during acupuncture treatment. When such circumstance will arise, the patient will be handled properly and recorded in a timely manner.